Enosis Therapeutics
Enosis Therapeutics and Psylo are leveraging technology in Australia to advance medicinal psychedelic therapy, with Enosis focusing on virtual reality tools for integration therapy and Psylo developing non-hallucinogenic synthetic compounds. Australia has become the first country to legalize psychedelic-assisted therapies for conditions like treatment-resistant depression and PTSD.
.png)
Summary
How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychedelics
Australia is quickly becoming a global test case for medicinal psychedelic therapy. Two local startups, Enosis Therapeutics and Psylo, are taking distinct approaches to it through tech. While Enosis is pioneering virtual reality (VR) tools to support integration therapy, Psylo is developing synthetic compounds inspired by psychedelics that offer non-hallucinogenic therapeutic potential.
In July 2023, Australia became the first country in the world to legalise psychedelic-assisted therapies for conditions like treatment-resistant depression and post-traumatic stress disorder (PTSD).
Other Articles
/w=1920,quality=90,fit=scale-down){kind=small}
/w=1920,quality=90,fit=scale-down)
